Geraldine Henwood insider trades: Baudax Bio (BXRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Geraldine reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 15, 2022 | BXRX | ↑ Buy | 1,200 | $2.55 | $3K | Direct | Dec 19, 2022 (4d) |
| Sep 22, 2021 | BXRX | ↑ Buy | 8,200 | $0.59 | $5K | Direct | Sep 23, 2021 (1d) |
| May 7, 2021 | BXRX | ↑ Buy | 6,000 | $0.83 | $5K | Direct | May 10, 2021 (3d) |
| Apr 17, 2020 | REPH | ↓ Sell | 80,000 | $8.22 | $658K | Direct | Apr 20, 2020 (3d) |
| May 13, 2019 | REPH | ↓ Sell | 144,806 | $8.89 | $1.3M | Direct | May 15, 2019 (2d) |
| Jun 8, 2015 | REPH | ↑ Buy | 4,500 | $8.92 | $40K | Direct | Jun 9, 2015 (1d) |
| Jan 15, 2014 | ALKS | ↓ Sell | 40,000 | $47.57 | $1.9M | Direct | Jan 17, 2014 (2d) |
| Aug 29, 2013 | ALKS | ↓ Sell | 20,000 | $31.68 | $634K | Direct | Aug 30, 2013 (1d) |
| Feb 28, 2013 | MAPP | ↓ Sell | 10,000 | $25.00 | $250K | Direct | Mar 4, 2013 (4d) |
| Nov 23, 2012 | MAPP | ↓ Sell | 5,240 | $15.00 | $79K | Direct | Nov 27, 2012 (4d) |
| Aug 27, 2012 | ALKS | ↓ Sell | 40,000 | $17.87 | $715K | Direct | Aug 28, 2012 (1d) |
| Feb 23, 2012 | ALKS | ↓ Sell | 48,000 | $17.29 | $830K | Direct | Feb 23, 2012 (0d) |
| Oct 27, 2010 | MAPP | ↓ Sell | 5,377 | $15.66 | $84K | Direct | Oct 29, 2010 (2d) |
| Oct 27, 2010 | MAPP | ↓ Sell | 4,387 | $15.66 | $69K | Direct | Oct 29, 2010 (2d) |
| Aug 5, 2010 | MAPP | ↓ Sell | 12,000 | $12.78 | $153K | Direct | Aug 6, 2010 (1d) |
| Nov 18, 2009 | MAPP | ↓ Sell | 16,250 | $8.77 | $142K | Direct | Nov 19, 2009 (1d) |
| Mar 10, 2006 | AUXL | ↑ Buy | 1,000 | $6.43 | $6K | Direct | Mar 14, 2006 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Geraldine Henwood's insider trades
Geraldine Henwood is President and CEO at Baudax Bio (BXRX). Since Mar 10, 2006, Geraldine has reported 5 open-market purchases worth $59K and 12 sales worth $6.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (38 filings), option exercises (16 filings), shares withheld for taxes (15 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BXRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.